Cargando…
In classical Hodgkin lymphoma the combination of the CCR5 antagonist maraviroc with trabectedin synergizes, enhances DNA damage and decreases three-dimensional tumor-stroma heterospheroid viability
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719077/ https://www.ncbi.nlm.nih.gov/pubmed/34498447 http://dx.doi.org/10.3324/haematol.2021.279389 |
_version_ | 1784624862502846464 |
---|---|
author | Casagrande, Naike Borghese, Cinzia Aldinucci, Donatella |
author_facet | Casagrande, Naike Borghese, Cinzia Aldinucci, Donatella |
author_sort | Casagrande, Naike |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8719077 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Fondazione Ferrata Storti |
record_format | MEDLINE/PubMed |
spelling | pubmed-87190772022-01-14 In classical Hodgkin lymphoma the combination of the CCR5 antagonist maraviroc with trabectedin synergizes, enhances DNA damage and decreases three-dimensional tumor-stroma heterospheroid viability Casagrande, Naike Borghese, Cinzia Aldinucci, Donatella Haematologica Letters to the Editor Fondazione Ferrata Storti 2021-09-09 /pmc/articles/PMC8719077/ /pubmed/34498447 http://dx.doi.org/10.3324/haematol.2021.279389 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Letters to the Editor Casagrande, Naike Borghese, Cinzia Aldinucci, Donatella In classical Hodgkin lymphoma the combination of the CCR5 antagonist maraviroc with trabectedin synergizes, enhances DNA damage and decreases three-dimensional tumor-stroma heterospheroid viability |
title | In classical Hodgkin lymphoma the combination of the CCR5 antagonist maraviroc with trabectedin synergizes, enhances DNA damage and decreases three-dimensional tumor-stroma heterospheroid viability |
title_full | In classical Hodgkin lymphoma the combination of the CCR5 antagonist maraviroc with trabectedin synergizes, enhances DNA damage and decreases three-dimensional tumor-stroma heterospheroid viability |
title_fullStr | In classical Hodgkin lymphoma the combination of the CCR5 antagonist maraviroc with trabectedin synergizes, enhances DNA damage and decreases three-dimensional tumor-stroma heterospheroid viability |
title_full_unstemmed | In classical Hodgkin lymphoma the combination of the CCR5 antagonist maraviroc with trabectedin synergizes, enhances DNA damage and decreases three-dimensional tumor-stroma heterospheroid viability |
title_short | In classical Hodgkin lymphoma the combination of the CCR5 antagonist maraviroc with trabectedin synergizes, enhances DNA damage and decreases three-dimensional tumor-stroma heterospheroid viability |
title_sort | in classical hodgkin lymphoma the combination of the ccr5 antagonist maraviroc with trabectedin synergizes, enhances dna damage and decreases three-dimensional tumor-stroma heterospheroid viability |
topic | Letters to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719077/ https://www.ncbi.nlm.nih.gov/pubmed/34498447 http://dx.doi.org/10.3324/haematol.2021.279389 |
work_keys_str_mv | AT casagrandenaike inclassicalhodgkinlymphomathecombinationoftheccr5antagonistmaravirocwithtrabectedinsynergizesenhancesdnadamageanddecreasesthreedimensionaltumorstromaheterospheroidviability AT borghesecinzia inclassicalhodgkinlymphomathecombinationoftheccr5antagonistmaravirocwithtrabectedinsynergizesenhancesdnadamageanddecreasesthreedimensionaltumorstromaheterospheroidviability AT aldinuccidonatella inclassicalhodgkinlymphomathecombinationoftheccr5antagonistmaravirocwithtrabectedinsynergizesenhancesdnadamageanddecreasesthreedimensionaltumorstromaheterospheroidviability |